POINT Biopharma Global Inc

XNAS: PNT

Watchlist

Portfolio

Share


Insider Trading disclosures for POINT Biopharma Global Inc

The latest disclosure was made by Kelly Justyna in POINT Biopharma Global Inc where a trade of 98,358 Stock Option (Right to Buy) done was reported to US exchanges on Dec. 27, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kelly Justyna Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2023 98,358 0 - - Stock Option (Right to Buy)
L. William Demers Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2023 179,362 0 - - Stock Option (Right to Buy)
Yael Margolin Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2023 44,749 0 - - Stock Option (Right to Buy)
William Demers L. Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2023 131,355 0 - - Stock Option (Right to Buy)
Yael Margolin Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2023 1,710 0 - - Common Stock
Margolin Yael Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2023 25,000 0 - - Stock Option (Right to Buy)
D. Jensen Jessica EVP Clinical Development Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2023 13,766 0 - - Stock Option (Right to Buy)
L. William Demers Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2023 16,767 0 - - Stock Option (Right to Buy)
Kelly Justyna Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2023 77,958 0 - - Stock Option (Right to Buy)
Jessica Jensen D. EVP Clinical Development Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2023 125,553 0 - - Stock Option (Right to Buy)
D. Jensen Jessica EVP Clinical Development Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2023 213,301 0 - - Stock Option (Right to Buy)
Jensen Jessica D. EVP Clinical Development Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2023 136,055 0 - - Stock Option (Right to Buy)
William Demers L. Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2023 105,360 0 - - Stock Option (Right to Buy)
Margolin Yael Director Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2023 25,614 0 - - Stock Option (Right to Buy)
Kelly Justyna Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2023 26,904 0 - - Stock Option (Right to Buy)
D. Jessica Jensen EVP Clinical Development Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2023 461,250 0 - - Stock Option (Right to Buy)
Kelly Justyna Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2023 70,000 0 - - Stock Option (Right to Buy)
Kelly Justyna Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 27 Dec 2023 4,932 0 - - Stock Option (Right to Buy)
David Charles Lubner Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Dec 2023 25,614 0 - - Stock Option (Right to Buy)
K. Rajesh Malik Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Dec 2023 25,000 0 - - Stock Option (Right to Buy)
L. Gerald Hogue Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Dec 2023 44,749 0 - - Stock Option (Right to Buy)
Goodman Jonathan Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Dec 2023 25,000 0 - - Stock Option (Right to Buy)
L. Gerald Hogue Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Dec 2023 25,614 0 - - Stock Option (Right to Buy)
K. Malik Rajesh Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Dec 2023 25,614 0 - - Stock Option (Right to Buy)
David Lubner Charles Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Dec 2023 25,000 0 - - Stock Option (Right to Buy)
David Charles Lubner Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Dec 2023 44,749 0 - - Stock Option (Right to Buy)
Gerald Hogue L. Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Dec 2023 25,000 0 - - Stock Option (Right to Buy)
Lubner David Charles Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Dec 2023 3,600 0 - - Common Stock
Malik Rajesh K. Director 26 Dec 2023 3,700 0 - - Common Stock
Lubner David Charles Director 26 Dec 2023 35,400 3,600 - - Common Stock
Goodman Jonathan Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Dec 2023 44,749 0 - - Stock Option (Right to Buy)
Jonathan Goodman Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Dec 2023 25,614 0 - - Stock Option (Right to Buy)
Goodman Jonathan Director 26 Dec 2023 41,872 0 - - Common Stock
Goodman Jonathan Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Dec 2023 35,872 0 - - Stock Option (Right to Buy)
Malik Rajesh K. Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Dec 2023 44,749 0 - - Stock Option (Right to Buy)
Gerald L. Hogue Director Sale or transfer of securities back to the company at price $ 0.00 per share. 26 Dec 2023 17,936 0 - - Stock Option (Right to Buy)
Hogue Gerald L. Director 26 Dec 2023 21,596 0 - - Common Stock
Neil Fleshner Director, Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Dec 2023 84,257 0 - - Stock Option (Right to Buy)
Silber C. Allan Director, Executive Chairman 22 Dec 2023 313,884 0 - - Common Stock
Fleshner Neil Director, Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Dec 2023 25,000 0 - - Stock Option (Right to Buy)
Silber Allan C. Director, Executive Chairman 22 Dec 2023 38,087 0 - - Common Stock
Allan C. Silber Director, Executive Chairman 22 Dec 2023 71,744 0 - - Common Stock
Allan C. Silber Director, Executive Chairman 22 Dec 2023 4,268,605 0 - - Common Stock
Neil Fleshner Director, Chief Medical Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Dec 2023 60,234 0 - - Stock Option (Right to Buy)
McCann Joe Director, Chief Executive Officer 22 Dec 2023 3,494,153 0 - - Common Stock
McCann Joe Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Dec 2023 381,795 0 - - Stock Option (Right to Buy)
Neil Fleshner Director, Chief Medical Officer 22 Dec 2023 233,171 0 - - Common Stock
Silber C. Allan Director, Executive Chairman Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Dec 2023 537,322 0 - - Stock Option (Right to Buy)
Fleshner Neil Director, Chief Medical Officer 22 Dec 2023 358 0 - - Common Stock
Silber C. Allan Director, Executive Chairman 22 Dec 2023 4,035,655 0 - - Common Stock
Joe McCann Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Dec 2023 692,643 0 - - Stock Option (Right to Buy)
Silber C. Allan Director, Executive Chairman Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Dec 2023 332,476 0 - - Stock Option (Right to Buy)
Fleshner Neil Director, Chief Medical Officer 22 Dec 2023 2,773,045 0 - - Common Stock
Allan C. Silber Director, Executive Chairman Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Dec 2023 6,787 0 - - Stock Option (Right to Buy)
McCann Joe Director, Chief Executive Officer 22 Dec 2023 2,160 0 - - Common Stock
Jonathan Goodman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 44,749 44,749 - - Stock Option (Right to Buy)
David Charles Lubner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 44,749 44,749 - - Stock Option (Right to Buy)
Rajesh K. Malik Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 44,749 44,749 - - Stock Option (Right to Buy)
Yael Margolin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 44,749 44,749 - - Stock Option (Right to Buy)
Gerald L. Hogue Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2023 44,749 44,749 - - Stock Option (Right to Buy)
Allan C. Silber Director, Executive Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2023 537,322 537,322 - - Stock Option (Right to Buy)
William L. Demers Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2023 131,355 131,355 - - Stock Option (Right to Buy)
Justyna Kelly Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2023 98,358 98,358 - - Stock Option (Right to Buy)
Neil Fleshner Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2023 84,257 84,257 - - Stock Option (Right to Buy)
Joe McCann Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2023 692,643 692,643 - - Stock Option (Right to Buy)
Jessica D. Jensen EVP Clinical Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2023 136,055 136,055 - - Stock Option (Right to Buy)
Gerald L. Hogue Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Mar 2023 17,936 17,936 - - Stock Option (Right to Buy)
Gerald L. Hogue Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.97 per share. 21 Mar 2023 17,936 21,596 - 7.0 125,014 Common Stock
Joe McCann Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 6.64 per share. 29 Nov 2022 2,160 3,616,313 - 6.6 14,342 Common Stock
Rajesh K. Malik Director Purchase of securities on an exchange or from another person at price $ 6.66 per share. 28 Nov 2022 3,700 3,700 - 6.7 24,642 Common Stock
Gerald L. Hogue Director Purchase of securities on an exchange or from another person at price $ 6.82 per share. 25 Nov 2022 3,660 3,660 - 6.8 24,943 Common Stock
David Charles Lubner Director Purchase of securities on an exchange or from another person at price $ 6.85 per share. 23 Nov 2022 3,600 3,600 - 6.9 24,660 Common Stock
Yael Margolin Director Purchase of securities on an exchange or from another person at price $ 6.56 per share. 21 Nov 2022 1,710 1,710 - 6.6 11,218 Common Stock
Jonathan Goodman Director Purchase of securities on an exchange or from another person at price $ 6.33 per share. 18 Nov 2022 6,000 41,872 - 6.3 37,980 Common Stock
Allan C. Silber Director, Executive Chairman, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 6.00 per share. 17 Nov 2022 27,603 4,246,208 - 6 165,618 Common Stock
Allan C. Silber Director, Executive Chairman, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 6.50 per share. 17 Nov 2022 22,397 4,268,605 - 6.5 145,581 Common Stock
Jonathan Goodman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 25,614 25,614 - - Stock Option (Right to Buy)
David Charles Lubner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 25,614 25,614 - - Stock Option (Right to Buy)
Yael Margolin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 25,614 25,614 - - Stock Option (Right to Buy)
Gerald L. Hogue Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 25,614 25,614 - - Stock Option (Right to Buy)
Rajesh K. Malik Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 25,614 25,614 - - Stock Option (Right to Buy)
Neil Fleshner Director, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 7.51 per share. 25 May 2022 564,204 3,023,045 - 7.5 4,237,172 Common Stock
Jessica D. Jensen EVP Clinical Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2022 13,766 13,766 - - Stock Option (Right to Buy)
Allan C. Silber Director, Executive Chairman, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2022 332,476 332,476 - - Stock Option (Right to Buy)
William L. Demers Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2022 105,360 105,360 - - Stock Option (Right to Buy)
Justyna Kelly Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2022 77,958 77,958 - - Stock Option (Right to Buy)
Jessica D. Jensen EVP Clinical Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2022 213,301 213,301 - - Stock Option (Right to Buy)
Joe McCann Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2022 381,795 381,795 - - Stock Option (Right to Buy)
Neil Fleshner Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2022 60,234 60,234 - - Stock Option (Right to Buy)
Justyna Kelly Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2021 70,000 70,000 - - Stock Option (Right to Buy)
Rajesh K. Malik Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jul 2021 25,000 25,000 - - Stock Option (Right to Buy)
Jonathan Goodman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jul 2021 25,000 25,000 - - Stock Option (Right to Buy)
David Charles Lubner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jul 2021 25,000 25,000 - - Stock Option (Right to Buy)
Margaret E. Gilmour Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jul 2021 25,000 25,000 - - Stock Option (Right to Buy)
Yael Margolin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jul 2021 25,000 25,000 - - Stock Option (Right to Buy)
Gerald L. Hogue Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jul 2021 25,000 25,000 - - Stock Option (Right to Buy)
William L. Demers Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jul 2021 16,767 16,767 - - Stock Option (Right to Buy)
Jessica D. Jensen EVP Clinical Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jul 2021 461,250 461,250 - - Stock Option (Right to Buy)
Michael Gottlieb Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jul 2021 48,000 48,000 - - Stock Option (Right to Buy)
Neil Fleshner Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jul 2021 25,000 25,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters